ReviewIrish journal of medical science2019
Change of paradigm in treating elderly with breast cancer: are we undertreating elderly patients?
Review in Irish journal of medical science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Development and validation of a SEER-based prognostic nomogram for overall survival in elderly Asian American women with breast cancer.Gland surgery · 2026Article
- Impact of Therapy on Health-Related Quality of Life in Breast Cancer Patients >60 Years.Breast care (Basel, Switzerland) · 2026Article
- Short-term outcomes and mortality in older patients with breast cancer at a single tertiary center.Surgery in practice and science · 2025Article
- Breast cancer diagnosis at age 85 and older.Breast cancer research and treatment · 2025Article
- Influence of breast cancer on life satisfaction in the elderly patient.Archives of gynecology and obstetrics · 2025Article
- The Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Elderly Breast Cancer Patients: What Do We Know?Cancers · 2024Review
- Have the recent advancements in cancer therapy and survival benefitted patients of all age groups across the Nordic countries? NORDCAN survival analyses 2002-2021.Acta oncologica (Stockholm, Sweden) · 2024Article
- Access to cancer clinical trials for racialised older adults: an equity-focused rapid scoping review protocol.BMJ open · 2024Article
- Healthcare delivery to elderly and unfit patients with breast disease and comorbidities under an outpatient regime: A report of a personal surgical technique named "Cut&Sew".Surgery open science · 2023Article
- A nomogram for predicting breast cancer specific survival in elderly patients with breast cancer: a SEER population-based analysis.BMC geriatrics · 2023Article
- Impact of Medical Specialties on Diagnostic and Therapeutic Management of Elderly Cancer Patients.Geriatrics (Basel, Switzerland) · 2023Article
- The role of family confidants and caregivers in the care of older cancer patients: Extending the concept of "shared decision-making".Health science reports · 2021Article
- Prevelance of upper extremity lymphedema and risk factors in patients with mastectomy: Single-center, observational, cross-sectional study.Turkish journal of obstetrics and gynecology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Developed countries face significant population ageing in the near future. Within 20 years, the average age will approach 50 years and the largest population cohort will be those over 65 years. The incidence of breast cancer increases with age, with a risk in women of 0.44% by the age of 30, 3.82% by the age of 70 and 10% by the age of 80. Breast cancer is responsible for one out of every three cancer-related deaths. Elderly patients have higher mortality rates and most breast cancer-related deaths are observed in women over 65. There appears to be a trend that elderly patients with breast cancer receive less than the standard treatment compared to younger counterparts and this leads to poorer outcomes. The rationale for treating elderly breast cancer patients more conservatively is that breast cancers in this cohort are more commonly oestrogen receptor (ER) positive which gives the clinician the option to treat with hormonal manipulation alone. In addition, elderly patients present at a later stage compared to younger patients who frequently present with early (stages I and II) breast cancer. This review aims to give an overview of the diagnosis, treatment options and surveillance of breast cancer in elderly women (over 75 years) and to discuss the change in perception of the term 'elderly' and the reasons for undertreatment in the elderly patients.
Indexed as
Identifiers
29934872What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.